Prostate-specific antigen testing for prostate cancer screening: A national survey of Canadian primary care physicians' opinions and practices
- PMID: 29106358
- PMCID: PMC5962947
- DOI: 10.5489/cuaj.4486
Prostate-specific antigen testing for prostate cancer screening: A national survey of Canadian primary care physicians' opinions and practices
Abstract
Introduction: In 2014, the Canadian Task Force on Preventive Health Care (CTFPHC) recommended against routine prostate cancer screening with the prostate-specific antigen (PSA) blood test. We surveyed Canadian primary care physicians (PCPs) to understand their opinions and attitudes towards prostate cancer screening in 2016.
Methods: Twenty PCPs piloted the survey to assess its accessibility. We distributed a flyer to 19 633 PCPs as an insert in a large mailed package inviting them to attend a national meeting, and later promoted the survey at the meeting. Multinomial logistic regression models examined factors associated with agreement of key guideline statements and the overall benefit of PSA screening.
Results: A total of 1254 PCPs responded (rate of 6.4%); 54.7% of physicians aware of the CTFPHC recommendations report screening less often as a result. Overall, 55.6% of PCPs feel that the risks of PSA screening outweigh the benefits. On multivariable analysis, physicians who did not read the guidelines, did not have an academic appointment, or were in practice for over 20 years were significantly more likely to disagree with the statement that men 55-69 years old should not be screened for prostate cancer with PSA.
Conclusions: Our national survey found that the prostate cancer screening practices of Canadian PCPs varies widely across physician demographic groups, with almost equal numbers for or against. This has significant ethical, medical, and legal implications. The poor response rate to highly incentivized survey request may suggest a reluctance or general apathy towards this subject because of the Task Force recommendations. Future efforts should provide physicians with objective guidance around PSA screening, incorporating input from all stakeholders, including PCPs, urologists, and patients.
Conflict of interest statement
Figures
![Fig. 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5962947/bin/CUAJ-12-g398-01.gif)
![Fig. 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5962947/bin/CUAJ-12-g399-01.gif)
![Fig. 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5962947/bin/CUAJ-12-g399-02.gif)
![Fig. 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5962947/bin/CUAJ-12-g400-01.gif)
![Fig. 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5962947/bin/CUAJ-12-g400-02.gif)
Similar articles
-
Prostate specific antigen screening for prostate cancer: knowledge of, attitudes towards, and utilization among primary care physicians.Urol Oncol. 2012 Mar-Apr;30(2):155-60. doi: 10.1016/j.urolonc.2009.12.019. Epub 2010 Aug 25. Urol Oncol. 2012. PMID: 20800514
-
Prostate cancer screening among family physicians in Ontario: An update on attitudes and current practice.Can Urol Assoc J. 2018 Feb;12(2):E53-E58. doi: 10.5489/cuaj.4631. Epub 2017 Dec 1. Can Urol Assoc J. 2018. PMID: 29381468 Free PMC article.
-
Prostate cancer screening practices amongst physicians in the North Simcoe Muskoka Local Health Integration Network.Can J Urol. 2017 Apr;24(2):8734-8739. Can J Urol. 2017. PMID: 28436360
-
Benefits and Harms of Prostate-Specific Antigen Screening for Prostate Cancer: An Evidence Update for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2008 Aug. Report No.: 08-05121-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2008 Aug. Report No.: 08-05121-EF-1. PMID: 20722160 Free Books & Documents. Review.
-
Primary care providers' cancer genetic testing-related knowledge, attitudes, and communication behaviors: A systematic review and research agenda.J Gen Intern Med. 2017 Mar;32(3):315-324. doi: 10.1007/s11606-016-3943-4. Epub 2016 Dec 19. J Gen Intern Med. 2017. PMID: 27995427 Free PMC article. Review.
Cited by
-
Strategies used in managing conversations about prostate-specific antigen (PSA) testing among family physicians (FPs): a qualitative study.BMJ Open. 2023 Apr 28;13(4):e073415. doi: 10.1136/bmjopen-2023-073415. BMJ Open. 2023. PMID: 37117002 Free PMC article.
-
Prostate Cancer Incidence and Mortality: Global Status and Temporal Trends in 89 Countries From 2000 to 2019.Front Public Health. 2022 Feb 16;10:811044. doi: 10.3389/fpubh.2022.811044. eCollection 2022. Front Public Health. 2022. PMID: 35252092 Free PMC article.
-
Global, regional, and national burden of kidney, bladder, and prostate cancers and their attributable risk factors, 1990-2019.Mil Med Res. 2021 Nov 24;8(1):60. doi: 10.1186/s40779-021-00354-z. Mil Med Res. 2021. PMID: 34819142 Free PMC article.
-
The times they are a-changin': The evolution of prostate cancer screening practices and beliefs among primary care physicians in Victoria, British Columbia.Can Urol Assoc J. 2021 Jun;15(6):192-196. doi: 10.5489/cuaj.6680. Can Urol Assoc J. 2021. PMID: 33212001 Free PMC article.
-
Which work-related characteristics are most strongly associated with common mental disorders? A cross-sectional study.BMJ Open. 2018 Aug 5;8(8):e020770. doi: 10.1136/bmjopen-2017-020770. BMJ Open. 2018. PMID: 30082345 Free PMC article.
References
-
- Statistics CCSACOC. Canadian Cancer Statistics 2015. Toronto, ON: Canadian Cancer Society; 2015.
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous